Nicola Donatiello

Nicola Donatiello has a robust background in quality assurance within the pharmaceutical industry, currently serving at Alfa Intes Industria Terapeutica Splendore since April 2023. Prior experience includes roles at Fresenius Kabi from July 2016 to April 2023 as Deputy Qualified Person and Quality Assurance, where responsibilities encompassed managing quality anomalies, deviations, and corrective actions (CAPA management), along with change control oversight. At Hikma Pharmaceuticals from April 2012 to July 2016, Nicola worked in Quality Assurance, ensuring Good Manufacturing Practice (GMP) compliance through monitoring production processes and handling documentation. Additionally, a research tenure at Università degli Studi di Pavia involved synthesizing nanocomposites for treating skin ulcers, enhancing expertise in techniques like lyophilization and spray drying. Educational qualifications include a Master's in Pharmaceutical Development and Control from Università di Pavia and a degree in Pharmaceutical Chemistry and Technology from Università degli Studi di Napoli Federico II.